Global Nootropics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 to 2024

  • ID: 4199148
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • AlternaScript LLC
  • Cephalon, Inc.
  • Ceretropic
  • Clarity Nootropics
  • Nootrico
  • Nootrobox, Inc.
  • MORE
Nootropics Market - Growth, Future Prospects and Competitive Analysis, 2016-2024, the global nootropics market was valued at USD 1,346.5 Mn in 2015, and is expected to reach USD 6,059.4 Mn by 2024, expanding at a CAGR of 17.9% from 2016 to 2024.

Market Insights

Nootropics, also known as cognitive enhancers are drugs and natural extracts that improve cognitive functions such as memory, creativity, motivation in healthy individuals. Nootropics have been available in the market for several decades and were made of ingredients such as multivitamins and caffeine - substances that the FDA has approved as dietary supplements and classified as GRAS (generally regarded as safe). At present, these products are being repackaged, repurposed and sold to academic and professional overachievers to augment their brain function. Companies operating in this space primarily succeed as lifestyle brands through smart marketing. However they can only be recognized as healthcare brands only after they develop products that secure regulatory approval thus establishing certified efficacy and safety to their products.

Among the key applications of nootropics, memory enhancement currently holds the largest revenue share and it is anticipated that the segment will maintain its lead through the forecast period 2016-2024. Major factors favoring the demand for memory enhancing nootropics include growing awareness among students and executives about the promised benefits of nootropics, easy accessibility, and the booming market for supplements. The memory enhancing nootropic drugs enhance learning and memory effect, enhance the ability of learned behaviors to resist disruption, enhance the efficiency of your brain functions and protect the brain from chemical injuries. Memory enhancement segment for nootropics was valued at USD 391.6 Mn in 2015.

Geographically, North America is the largest consumer of nootropics and is also characterized by domicile of topmost market players. Large population pool, high awareness in consumer population for preventive and cognitive health, rise of the self-directed consumer, and channel proliferation are the key factors driving the dominance of North America nootropics market. On the other hand, Asia Pacific is anticipated to be the fastest progressing regional market for nootropics. While in countries like China and India having a great history of natural and herbal based cognitive drugs that boosts the brain functions and other body functions, the foreign investment in collaboration with the local players have determined substantial growth in the nootropics market and the overall dietary supplements market.

Nootropics is a relatively new entrant in the supplements market and is featured by emergence of several new and niche market entrants. Some of the key players in the global nootropics market are Nootrobox Inc., Cephalon Inc., PureLife Bioscience Co. Ltd., Peak Nootropics, Nootrico, SupNootropic Biological Technology Co. Ltd., AlternaScript LLC, Accelerated Intelligence Inc., Onnit Labs LLC, Powder City LLC, Ceretropics, Nootropic Source, Clarity Nootropics and several others.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AlternaScript LLC
  • Cephalon, Inc.
  • Ceretropic
  • Clarity Nootropics
  • Nootrico
  • Nootrobox, Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Nootropics Market Portraiture
2.2 Global Nootropics Market, by Type of Application, 2015 (USD Mn)
2.3 Global Nootropics Market Share, by Geography, 2015 (Value %)

Chapter 3 Nootropics Market Analysis
3.1 Global Nootropics Market Overview
3.2 Top 30 Drug Profiles
3.2.1 Adrafinil
3.2.2 Phenylpiracetam (Phenotropil)
3.2.3 Noopept
3.2.4 Sulbutiamine
3.2.5 Pramiracetam
3.2.6 Sunifiram
3.2.7 Piracetam
3.2.8 Oxiracetam
3.2.9 Aniracetam
3.2.10 Magnesium Citrate
3.2.11 Alpha- GPC
3.2.12 CDP-choline
3.2.13 Gynostemma
3.2.14 Ashwagandha
3.2.15 Bacopa Monnieri
3.2.16 Phenibut
3.2.17 Rhodila Rosea
3.2.18 Galantamine
3.2.19 Phenylethylamine (PEA)
3.2.20 Alpha-Lipoic Acid (ALA)
3.2.21 Uridine Monophosphate
3.2.22 Centrophenoxine
3.2.23 L-Dopa
3.2.24 N-Acetyl-Cysteine
3.2.25 L-theanine
3.2.26 Acetyl L-Cartinine
3.2.27 Huperzine A
3.2.28 Picamilon
3.2.29 Vinpocetine
3.2.30 Ginkgo Biloba
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Booming Supplements Industry
3.3.1.2 Sales Channel Proliferation
3.3.2 Challenges
3.3.2.1 Increase in Regulatory Pressures
3.3.3 Opportunities
3.3.3.1 Growth of E-commerce
3.4 Attractive Investment Proposition
3.5 Competitive Landscape of Key Players in Nootropics Market

Chapter 4 Global Nootropics Market Analysis, by Applications
4.1 Introduction
4.2 Memory Enhancement
4.3 Mood and Depression
4.4 Attention and Focus
4.5 Longevity and Anti-aging
4.6 Sleep, Recovery and Dream Enhancement
4.7 Anxiety

Chapter 5 Global Nootropics Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Nootrobox, Inc.
6.2 Cephalon, Inc.
6.3 Purelife Bioscience Co. Ltd.
6.4 Peak Nootropics
6.5 Nootrico
6.6 SupNootropic Biological Technology Co. Ltd.
6.7 AlternaScript LLC
6.8 Accelerated Intelligence, Inc.
6.9 Onnit Labs LLC
6.10 Powder City LLC
6.11 Ceretropic
6.12 Nootropic Source
6.13 Clarity Nootropics

List of Figures
Fig. 1 Nootropics Market: Research Methodology
Fig. 2 Global Nootropics Market, by Type of Application, 2015 (USD Mn)
Fig. 3 Global Nootropics Market Share, by Geography, 2015 (Value %)
Fig. 4 Attractive Investment Proposition: Global Nootropics Market, by Geography
Fig. 5 Global Nootropics for Memory Enhancement Market, 2014 - 2024 (USD Mn)
Fig. 6 Global Nootropics for Mood and Depression Market, 2014 - 2024 (USD Mn)
Fig. 7 Global Nootropics for Attention and Focus Market, 2014 - 2024 (USD Mn)
Fig. 8 Global Nootropics for Longevity and Anti-aging Market, 2013 - 2024 (USD Mn)
Fig. 9 Global Nootropics for Sleep, Recovery and Dream Enhancement Market, 2014 - 2024 (USD Mn)
Fig. 10 Global Nootropics for Anxiety Market, 2014 - 2024 (USD Mn)
Fig. 11 Latin America Nootropics Market, 2014 - 2024 (USD Mn)
Fig. 12 Middle East and Africa Nootropics Market, 2014 - 2024 (USD Mn)

List of Tables
Table 1 Market Positioning of Key Players in Global Nootropics Market
Table 2 Global Nootropics Market, by Application, 2014 - 2024 (USD Mn)
Table 3 Global Nootropics Market, by Geography, 2014 - 2024 (USD Mn)
Table 4 North America Nootropics Market, by Country, 2014 - 2024 (USD Mn)
Table 5 Europe Nootropics Market, by Country, 2014 - 2024 (USD Mn)
Table 6 Asia Pacific Nootropics Market, by Country, 2014 - 2024 (USD Mn)
Table 7 Nootrobox, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 8 Cephalon, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 9 Purelife Bioscience Co. Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 10 Peak Nootropics: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 11 Nootrico: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 12 SupNootropic Biological Technology Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 13 AlternaScript LLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 14 Accelerated Intelligence, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 15 Onnit Labs LLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 16 Powder City LLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 17 Ceretropic: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 18 Nootropic Source: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 19 Clarity Nootropics: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Nootrobox, Inc.
  • Cephalon, Inc.
  • Purelife Bioscience Co. Ltd.
  • Peak Nootropics
  • Nootrico
  • SupNootropic Biological Technology Co. Ltd.
  • AlternaScript LLC
  • Accelerated Intelligence, Inc.
  • Onnit Labs LLC
  • Powder City LLC
  • Ceretropic
  • Nootropic Source
  • Clarity Nootropics
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll